Synapse - Mark Weiss

Results (86)

CD52 expression in acute leukemia and advanced MDS: 118 cases at Memorial Sloan-Kettering Cancer Center

Meeting Abstract

Gupta, S.; Lamanna, N.; Rose, R.; Maslak, P. G.; Weiss, M. A.
Blood (2003)

Interim results from a phase I study of lumiliximab (IDEC-152, Anti-CD23 antibody) therapy for relapsed or refractory CLL

Meeting Abstract

Byrd, J. C.; O'Brien, S.; Flinn, I.; Kipps, T. J.; Weiss, M. A.; Reid, J.; Wynne, D.; Leigh, B. R.
Blood (2003)

Fulltext@MSK | Save

Pentostatin and cyclophosphamide: An effective new regimen in previously treated patients with chronic lymphocytic leukemia

Journal Article

Weiss, M. A.; Maslak, P. G.; Jurcic, J. G.; Scheinberg, D. A.; Aliff, T. B.; Lamanna, N.; Frankel, S. R.; Kossman, S. E.; Horgan, D.
Journal of Clinical Oncology (2003)

Fulltext@MSK | Save

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15

Journal Article

Brentjens, R. J.; Latouche, J. B.; Santos, E.; Marti, F.; Gong, M. C.; Lyddane, C.; King, P. D.; Larson, S.; Weiss, M.; Rivière, I.; more...
Nature Medicine (2003)

Fulltext@MSK | Save

Refractory aspergillus pneumonia in patients with acute leukemia: Successful therapy with combination caspofungin and liposomal amphotericin

Journal Article

Aliff, T. B.; Maslak, P. G.; Jurcic, J. G.; Heaney, M. L.; Cathcart, K. N.; Sepkowitz, K. A.; Weiss, M. A.
Cancer (2003)

Fulltext@MSK | Save

Chronic lymphocytic leukemia

Book Section

Cortes, J. E.; O'Brien, S.; Weiss, M. A.; Kantarjian, H.
In Pazdur, R.; Coia, L. R.; Hoskins, W. J.; Wagman, L. D. (Eds.) Cancer Management: A Multidisciplinary Approach. 6th ed (2002)

Fulltext@MSK | Save

Sequential therapy with fludarabine, high dose cyclophosphamide, and rituximab improves the quality of response in patients with previously untreated chronic lymphocytic leukemia

Meeting Abstract

Weiss, M. A.; Lamanna, N.; Gencarelli, A.; Scheinberg, D. A.; Maslak, P. G.; Horgan, D.
Blood (2002)

Fulltext@MSK | Save

A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia

Journal Article

Weiss, M. A.; Aliff, T. B.; Tallman, M. S.; Frankel, S. R.; Kalaycio, M. E.; Maslak, P. G.; Jurcic, J. G.; Scheinberg, D. A.; Roma, T. E.
Cancer (2002)

Fulltext@MSK | Save

Acute leukemias

Book Section

Scheinberg, D. A.; Maslak, P.; Weiss, M.
In DeVita, V. T. Jr; Hellman, S.; Rosenberg, S. A. (Eds.) Cancer: Principles and Practice of Oncology. 6th ed (2001)

Fulltext@MSK | Save

Pentostatin and cyclophosphamide: A new active regimen for patients with fludarabine refractory CLL

Meeting Abstract

Weiss, M. A.; Maslak, P. G.; Jurcic, J. G.; Scheinberg, D. A.; Horgan, D. E.
Blood (2001)

Fulltext@MSK | Save